Mind Medicine Inc (NEOE:MMED)
C$ 14.9 1.29 (9.48%) Market Cap: 1.05 Bil Enterprise Value: 934.33 Mil PE Ratio: 0 PB Ratio: 2.57 GF Score: 22/100

Q3 2024 Mind Medicine (MindMed) Inc Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMT
Operator

Good afternoon and welcome to Mind Medicine third-quarter 2024 financial results and corporate update conference call. (Operator Instructions) This call is being webcast live on the investors and media section of MindMed's website at mindmed.co, and a recording will be available after the call.

I would like to introduce Stephanie Fagan, Chief Corporate Affairs Officer at MindMed. Please go ahead.

Stephanie Fagan;MindMed;Inc;Chief Corporate Affairs Officer
Mind Medicine

()-

Thank you, operator. Good afternoon, everyone. Thank you for joining us today for a discussion of Mindmed's third quarter, 2024 business highlights and financial results leading the call today will be Rob Barrow, our Chief Executive Officer. He will be joined by Dr Dan Carlin, our Chief Medical Officer and Francois Lonca, our Chief Commercial Officer.

After our prepared remarks, we will open the call for Q&A an audio recording and webcast replay for today's conference call will also be available online as detailed in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot